Harold S. Koplewicz

Add links
Source: Wikipedia, the free encyclopedia.
Harold Koplewicz
Born
Harold Samuel Koplewicz

(1953-01-12) January 12, 1953 (age 71)
Crown Heights, Brooklyn
NationalityAmerican
OccupationChild psychiatrist

Harold Samuel Koplewicz (/ˈkɒpləwɪts/ KOP-lə-wits;[1] born January 12, 1953) is a nationally known child and adolescent psychiatrist.[2] He is the founder and president of the nonprofit Child Mind Institute and editor-in-chief of the Journal of Child and Adolescent Psychopharmacology.[3]

Early life and education

Harold Koplewicz was born in

idiopathic thrombocytopenic purpura.[4]

Koplewicz earned a bachelor's degree in psychology from the

University of Maryland. He initially went to medical school for pediatrics, but eventually transferred to a general psychiatric residency, earning his Doctor of Medicine degree from Albert Einstein College of Medicine.[4][5]

Professional career

According to The New York Times in 1996, Koplewicz was:

Chief of child and adolescent psychiatry at Schneider Children's Hospital and Hillside Hospital at the Long Island Jewish Medical Center. After graduating from the Albert Einstein College of Medicine, Dr. Koplewicz completed a pediatric internship at the Bronx Municipal Hospital Center. He studied general psychiatry at Cornell University and completed a two-year research fellowship through the National Institute of Mental Health.[6]

In 1997 he helped found and served as the first director of the NYU Child Study Center (CSC), a position he held until he left NYU in October 2009.

Delcath from 2007 to 2011.[8][9] While Koplewicz worked at NYU Langone, he also served as the director of the Nathan S. Kline Institute for Psychiatric Research, a psychiatric facility run by the state of New York. In 2011 Koplewicz was dismissed from this role following a dispute with Jeffrey A. Sachs, the newly installed advisor on health care issues to the Governor.[10]

In 2007, an advertising campaign for the Child Study Center raised objections over its use of simulated ransom notes, seemingly addressed to parents of autistic children. The campaign was abandoned.[11]

After leaving NYU in 2009 Koplewicz started the Child Mind Institute.[12] Two CSC board members left with Koplewicz to serve as co-chairs of his new board of directors.[13] Koplewicz serves as the medical director of the clinic, president of the foundation, and practices on a limited basis.[13]

Paxil Study 329 controversy

See also:
Paxil § Controversy, and Side Effects (Bass book)

In 2001 Koplewicz was one of 22 co-authors of a study referred to as

Paxil (Paroxetine) and concluded that Paxil "is generally well-tolerated and effective for major depression in adolescents" (p. 762).[15] The report and conclusions were then used by GSK to market the drug to children.[16] In October 2011 the company was sued by the United States Department of Justice (DOJ) for false claims and for a fraudulent scheme to deceive and defraud,[17] and charged that the company touted the study 329 and journal article "that it paid to have drafted and that exaggerated Paxil's efficacy while downplaying risks identified in one of the trials."[17] In the summer of 2012 GSK settled the lawsuit with the DOJ for a record $3 billion (and more recently the State of North Carolina for $32 million).[16]

Publications and awards

Koplewicz has edited or authored more than 65 peer-reviewed articles and chapters on child and adolescent psychiatry.[18] He is also the editor, author or contributor to several books, including the textbook Depression in Children and Adolescents (Hardwood, 1993); It's Nobody's Fault: New Hope and Help for Difficult Children and Their Parents;[19] Childhood Revealed: Art Expressing Pain, Discovery & Hope;[20] Turbulent Times, Prophetic Dreams: Art of Palestinian and Israeli Children (2000);[21] More Than Moody: Recognizing and Treating Adolescent Depression;[22] and The Day Our World Changed: Children's Art of 9/11.[23]

He has received a number of industry awards,

Catcher in the Rye Award from the American Academy of Child and Adolescent Psychiatry, the 2007 Irving Philips Award for Prevention, the 2009 American Psychiatric Association McAlpin Award for lifetime contributions to child psychiatry, the 2010 American Society for Adolescent Psychiatry William Schonfeld Award, and the 2020 Albert Einstein College of Medicine[24]
Dominick P. Purpura Distinguished Alumni Award.

See also

References

  1. ^ "Harold S. Koplewicz Speak Up For Kids Welcome". YouTube. Archived from the original on 2021-12-21. Retrieved 5 September 2020.
  2. ^ "Are ADHD Medications Overprescribed?". The Wall Street Journal. 2012-09-14. Retrieved 2013-01-04.
  3. S2CID 144413524
    .
  4. ^ a b c d e Ellin, Abby (June 3, 2011). "When a Child's Anxieties Need Sorting". The New York Times. Retrieved March 4, 2017.
  5. ^ "Harold S. Koplewicz, MD". Child Mind Institute. February 4, 2016. Retrieved March 4, 2017.
  6. ^ Tagliaferro, Linda (16 June 1996). "Long Island Q & A: Dr. Harold S. Koplewicz;Helping to Combat Child and Adolescent Mental Disorders". The New York Times.
  7. ^ Kaminer, Ariel (2013-03-03). "N.Y.U. Gives Lavish Parting Gifts to Some Star Officials". The New York Times.
  8. ^ "Delcath dismisses CEO as FDA denies product approval". Albany Business Review. September 13, 2013. Retrieved February 2, 2018.
  9. ^ The New York Times (September 12, 2017). "Answers About Child Psychiatry". City Room. Retrieved February 2, 2018.
  10. ^ Confessore, Nicholas (February 23, 2011). "Jeffrey Sachs, Cuomo Adviser, Takes Health Industry Pay". The New York Times. Retrieved February 2, 2018.
  11. ^ Kaufman, Joanne (20 December 2007). "Ransom-Note Ads About Children's Health Are Canceled". The New York Times.
  12. ^ "Harold S. Koplewicz, MD Child Mind Institute". Child Mind Institute.
  13. ^ a b Ellin, Abby (2011-06-03). "When a Child's Anxieties Need Sorting". The New York Times.
  14. PMID 11437014
    .
  15. ^ "Clinical trials and drug promotion: Selective reporting of study 329 - The International Journal of Risk and Safety in Medicine - Volume 20, Number 1-2 / 2008 - IOS Press". Iospress.metapress.com. Archived from the original on 2013-01-28. Retrieved 2013-01-04.
  16. ^ a b "Thompson & Tredennick GSK Receives Criticism for Handling of Paxil Study". Ttlaw.com. 2012-09-18. Retrieved 2013-01-04.
  17. ^ a b Court document justice.gov
  18. ^ a b "Delcath Systems, Inc. - Harold Koplewicz, MD-new Board member - DCTH". InvestorVillage. Retrieved 2013-01-04.
  19. OCLC 58540289
    .
  20. OCLC 749171278
    .
  21. OCLC 45501112
    .
  22. OCLC 472864187
    .
  23. OCLC 682180408
    .
  24. ^ "Alumni Awards | Alumni". Albert Einstein College of Medicine. Retrieved 2023-09-22.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Harold_S._Koplewicz&oldid=1216956574"